John Kirby

Track

Insider profile

Currently holds a position at Idera Pharmaceuticals Inc

Performance

Overall performance
1.0
Performance over holding periods
1.0
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 20% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Principal Financial Officer and Accounting Officer Idera Pharmaceuticals Inc Oct. 31, 2018 -
Chief Accounting Officer, Vice President Shire Viropharma Inc Aug. 20, 2012 - Jan. 24, 2014
John Kirby's trades of Verrica Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
482.81
Quantity 82,090
Value US$2,672,459
Transaction date
Purchase
Price
0.62
Quantity 10,000 +36.2%
Value US$6,150
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-18
B Purchase
53,630 -47.6%
133.11
US$1,315,214 		53,630 -47.6% 133.11 US$1,315,214
2025-11-25 2025-11-25
B Purchase
88,628 +46.9%
251.92
US$3,979,961 		88,628 +46.9% 251.92 US$3,979,961
2023-07-25 2023-07-25
PrS Proposed sale
82,090
482.81
US$2,672,459 		82,090 482.81 US$2,672,459
2021-12-21 2021-12-17
B Purchase
10,000 +36.2%
0.62
US$6,150 		10,000 +36.2% 0.62 US$6,150
2021-03-29 2021-03-25
S Sale
6,250 -18.4%
1.42
US$8,876 		6,250 -18.4% 1.42 US$8,876
2021-01-12 2021-01-12
S Sale
1,693 -4.8%
4.22
US$7,152 		1,693 -4.8% 4.22 US$7,152
2021-01-06 2021-01-05
S Sale
862 -2.4%
3.90
US$3,362 		862 -2.4% 3.90 US$3,362
2020-01-10 2020-01-07
S Sale
911 -5.3%
1.78
US$1,622 		911 -5.3% 1.78 US$1,622